News

Hims & Hers short interest at critical levels after best weekly gain: report
The short interest in Hims & Hers Health (NYSE:HIMS) has approached critical levels, financial data provider S3 Partners said ...
Up 30% In A Week, HIMS Stock Is Just Getting Warmed Up
Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant ...
Trending stocks as U.S.market posts another week of rebound
The U.S. stock market continued to rebound from a period of volatility for the second straight week, with the S&P 500 closing ...
Money Morning4d
Hims & Hers (HIMS) Stock Just Popped: Are You Too Late to the Party?
In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.
Wegovy to be sold on Hims, Ro and LifeMD for reduced price
Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...
Hims & Hers: Selling Options On This High-Growth Gem Could Yield 20% Or More (Rating Upgrade)
Overall, though, we'd argue that HIMS's stock is in a great position to sell puts on. At this price, the options pay a ...
Zacks Investment Research on MSN1d
Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?
Hims & Hers Health, Inc. HIMS is scheduled to report first-quarter 2025 results on May 5, after the closing bell. In the last ...